Edwards Lifesciences Corporation · NYSE:EW
Edwards Lifesciences — 2021 Edwards Lifesciences Investor Conference
17 slides from Edwards Lifesciences's conference presentation, Dec 8, 2021
Slide 1: Critical Care
Critical Care Katie M. Szyman Corporate Vice President, Critical Care
Slide 2: Our vision is to improve the quality of care for millions
Our vision is to improve the quality of care for millions Leading Smart Recovery with AI enabled technologies Reaching more patients with compelling clinical evidence Improving patient care with adoption of innovative solutions
Slide 3: We continue to shift mix towards Smart Recovery
We continue to shift mix towards Smart Recovery TODAY TOMORROW Smart Monitoring Smart Monitoring Growth Potential Growth Potential Capital and Software Capital and Software Core Monitoring Core Monitoring Share of Revenue Share of Revenue Smart Monitoring Faster Recovery Smart Recovery 12/8/2021 3
Slide 4: Shift to Smart Recovery accelerates long-term growth
Shift to Smart Recovery accelerates long-term growth HEMODYNAMIC MONITORING MARKET 2021 2028 Pressure Monitoring is highly penetrated and is a large portion of the overall Core Core ~$1.8B hemodynamic segment Monitoring ~$1.1B Monitoring Hemodynamic Hemodynamic Segment Breakdown1 Segment Smart Break
Slide 5: Building blocks for Smart Recovery acceleration
Building blocks for Smart Recovery acceleration Technology Evidence Adoption Deploying the Right Generating Compelling Creating Solutions that Technologies Clinical Evidence Drive Adoption 12/8/2021 5
Slide 6: Smart Recovery Begins with Technology
Smart Recovery Begins WITH TECHNOLOGY SENSORS Connects patient and monitor ALGORITHMS 94 Enables smarter patient care SMART MONITORING PLATFORM HemoSphere builds the foundation 12/8/2021 6
Slide 7: HemoSphere platform builds foundation for growth
HemoSphere platform builds foundation for growth Two HemoSphere Offerings Phased rollout to replace legacy platforms 2018 2021 2028 Cardiac Swan-Ganz 94 Acumen IQ HPI Sensor & HPI Cardiac Smart Recovery Vigilance II Replacement ForeSight SIGHT FORE Non-Cardiac Non-Cardiac Smart Recovery 94 Acumen IQ
Slide 8: "Smartify" to improve patient care
“Smartify” to improve patient care Legacy… …Today and Beyond SENSORS SMART SENSORS Machine Data Learning Analytics FLOTRAC CLEARSIGHT SWAN-GANZ SENSOR CUFF CATHETER 2018 2021 “Smartify” DESCRIPTIVE ALGORITHM SMART ALGORITHM Clinical Connectivity CO BP SV Insights 94 92 HPI AFM Future Algorithms 2018
Slide 9: Connectivity solution enables remote patient care
Connectivity solution enables remote patient care Viewfinder Remote App HemoSphere FDA clearance received 2021 9:41 Track on Hospital phone EMR Multiple patients Insights anywhere The Viewfinder Remote App enables remote patient supervision and earlier intervention 12/8/2021 9
Slide 10: Smart Recovery Advances with Evidence
Smart Recovery Advances WITH EVIDENCE Hypotension Prediction Index (HPI) Data On Label Acumen IQ mix increasing Mean Minutes of Hypotension Acumen IQ Sensor FloTrac Classic 28 mins 12 mins 58% Decrease in IOH Edwards MPOG Study1 2021 Future HPI software proven to reduce hypotension 1. Edwards MPOG S
Slide 11: Hypotension can be prevented
Hypotension can be prevented Top 5 Global Causes of Death1 (percent of total) Hypotension is associated with increased risk of postoperative mortality2 17% of surgical patients 10% 88% experience hypotension3 8% 5% 4% Intraoperative hypotension seems to be a threat to patient safety that is hiding i
Slide 12: New study evaluating HPI's impact on outcomes
New study evaluating HPI’s impact on outcomes HPI SMART BP Timeline U.S. Adaptive multi-center RCT First Patient 50% Enrollment Anticipated Enrolled Complete Study Completion Q4 2021 Q4 2022 Q4 2023 Objectives ▪ Generate clinical outcomes linking HPI software to clinical benefit for intraoperative a
Slide 13: Smart Recovery Expands with Adoption
Smart Recovery Expands WITH ADOPTION Hypotension Quality Measure Real World Evidence Intraoperative Hypotension (IOH) Leverage data registries to demonstrate quality measure approved by CMS IOH association with increased risk Measure endorsed by ASA with Quality improvement projects using initial ta
Slide 14: 2022 Underlying Global Sales Growth Outlook
2022 Underlying Global Sales Growth Outlook Headwinds $900M Tailwinds Long conversion Rebound in hospital cycles $820M capital budgets Discontinuing Impact of clinical non-strategic products evidence on adoption 2022E Underlying Global Critical Care Estimated Sales Growth Mid single-digits 12/8/2021
Slide 15: Executive Summary
Executive Summary Leading Smart Recovery with AI enabled technologies Reaching more patients with compelling clinical evidence Improving patient care with adoption of innovative solutions 12/8/2021 15
Slide 16: CAUTION: Federal (USA) law restricts these devices to sale by or on the order
CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events. For professional use. For a listing of indications, contraindic
Slide 17: | PE TN
| PE TN Re IND, a ve Edwards Helping Patients is Our Life’s Work, and, now) fife”
Edwards Lifesciences — 2021 Edwards Lifesciences Investor Conference on 6ix